Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-31

FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for venlafaxine by Alembic Pharmaceuticals Inc. to support a generic version of the antidepressant. This action reflects…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE)